Geode Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.63B | Buy |
|
|||||
|
2025
Q1 | $2.78B | Buy |
|
|||||
|
2024
Q4 | $2.27B | Sell |
|
|||||
|
2024
Q3 | $2.75B | Sell |
|
|||||
|
2024
Q2 | $2.96B | Buy |
|
|||||
|
2024
Q1 | $2.42B | Buy |
|
|||||
|
2023
Q4 | $2.3B | Buy |
|
|||||
|
2023
Q3 | $1.94B | Buy |
|
|||||
|
2023
Q2 | $1.95B | Buy |
|
|||||
|
2023
Q1 | $1.7B | Buy |
|
|||||
|
2022
Q4 | $1.55B | Buy |
|
|||||
|
2022
Q3 | $1.52B | Buy |
|
|||||
|
2022
Q2 | $1.28B | Buy |
|
|||||
|
2022
Q1 | $1.13B | Sell |
|
|||||
|
2021
Q4 | $954M | Buy |
|
|||||
|
2021
Q3 | $778M | Buy |
|
|||||
|
2021
Q2 | $822M | Buy |
|
|||||
|
2021
Q1 | $845M | Buy |
|
|||||
|
2020
Q4 | $916M | Buy |
|
|||||
|
2020
Q3 | $1.05B | Buy |
|
|||||
|
2020
Q2 | $1.11B | Buy |
|
|||||
|
2020
Q1 | $905M | Buy |
|
|||||
|
2019
Q4 | $780M | Buy |
|
|||||
|
2019
Q3 | $585M | Buy |
|
|||||
|
2019
Q2 | $613M | Buy |
|
|||||
|
2019
Q1 | $594M | Buy |
|
|||||
|
2018
Q4 | $506M | Buy |
|
|||||
|
2018
Q3 | $548M | Buy |
|
|||||
|
2018
Q2 | $472M | Buy |
|
|||||
|
2018
Q1 | $444M | Buy |
|
|||||
|
2017
Q4 | $390M | Buy |
|
|||||
|
2017
Q3 | $380M | Buy |
|
|||||
|
2017
Q2 | $307M | Buy |
|
|||||
|
2017
Q1 | $255M | Buy |
|
|||||
|
2016
Q4 | $158M | Buy |
|
|||||
|
2016
Q3 | $178M | Buy |
|
|||||
|
2016
Q2 | $171M | Buy |
|
|||||
|
2016
Q1 | $158K | Buy |
|
|||||
|
2015
Q4 | $244M | Buy |
|
|||||
|
2015
Q3 | $199M | Buy |
|
|||||
|
2015
Q2 | $234M | Sell |
|
|||||
|
2015
Q1 | $226M | Buy |
|
|||||
|
2014
Q4 | $218M | Buy |
|
|||||
|
2014
Q3 | $196M | Buy |
|
|||||
|
2014
Q2 | $165M | Sell |
|
|||||
|
2014
Q1 | $123M | Buy |
|
|||||
|
2013
Q4 | $127M | Buy |
|
|||||
|
2013
Q3 | $125M | Buy |
|
|||||
|
2013
Q2 | $72.4M | Buy |
|